Global Age Related Macular Degeneration (AMD) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Age Related Macular Degeneration (AMD) market size was valued at US$ 7557.7 million in 2023. With growing demand in downstream market, the Age Related Macular Degeneration (AMD) is forecast to a readjusted size of US$ 11380 million by 2030 with a CAGR of 6.0% during review period.
The research report highlights the growth potential of the global Age Related Macular Degeneration (AMD) market. Age Related Macular Degeneration (AMD) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Age Related Macular Degeneration (AMD). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Age Related Macular Degeneration (AMD) market.
Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
Key Features:
The report on Age Related Macular Degeneration (AMD) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Age Related Macular Degeneration (AMD) market. It may include historical data, market segmentation by Type (e.g., Wet AMD, Dry AMD), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Age Related Macular Degeneration (AMD) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Age Related Macular Degeneration (AMD) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Age Related Macular Degeneration (AMD) industry. This include advancements in Age Related Macular Degeneration (AMD) technology, Age Related Macular Degeneration (AMD) new entrants, Age Related Macular Degeneration (AMD) new investment, and other innovations that are shaping the future of Age Related Macular Degeneration (AMD).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Age Related Macular Degeneration (AMD) market. It includes factors influencing customer ' purchasing decisions, preferences for Age Related Macular Degeneration (AMD) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Age Related Macular Degeneration (AMD) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Age Related Macular Degeneration (AMD) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Age Related Macular Degeneration (AMD) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Age Related Macular Degeneration (AMD) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Age Related Macular Degeneration (AMD) market.
Market Segmentation:
Age Related Macular Degeneration (AMD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Age Related Macular Degeneration (AMD) market size was valued at US$ 7557.7 million in 2023. With growing demand in downstream market, the Age Related Macular Degeneration (AMD) is forecast to a readjusted size of US$ 11380 million by 2030 with a CAGR of 6.0% during review period.
The research report highlights the growth potential of the global Age Related Macular Degeneration (AMD) market. Age Related Macular Degeneration (AMD) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Age Related Macular Degeneration (AMD). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Age Related Macular Degeneration (AMD) market.
Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
Key Features:
The report on Age Related Macular Degeneration (AMD) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Age Related Macular Degeneration (AMD) market. It may include historical data, market segmentation by Type (e.g., Wet AMD, Dry AMD), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Age Related Macular Degeneration (AMD) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Age Related Macular Degeneration (AMD) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Age Related Macular Degeneration (AMD) industry. This include advancements in Age Related Macular Degeneration (AMD) technology, Age Related Macular Degeneration (AMD) new entrants, Age Related Macular Degeneration (AMD) new investment, and other innovations that are shaping the future of Age Related Macular Degeneration (AMD).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Age Related Macular Degeneration (AMD) market. It includes factors influencing customer ' purchasing decisions, preferences for Age Related Macular Degeneration (AMD) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Age Related Macular Degeneration (AMD) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Age Related Macular Degeneration (AMD) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Age Related Macular Degeneration (AMD) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Age Related Macular Degeneration (AMD) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Age Related Macular Degeneration (AMD) market.
Market Segmentation:
Age Related Macular Degeneration (AMD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Wet AMD
- Dry AMD
- Men
- Woman
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- F. HoffmannLa Roche
- Regeneron
- Novartis
- Valeant
- Pfizer
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Age Related Macular Degeneration (AMD) Market Size 2019-2030
2.1.2 Age Related Macular Degeneration (AMD) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Age Related Macular Degeneration (AMD) Segment by Type
2.2.1 Wet AMD
2.2.2 Dry AMD
2.3 Age Related Macular Degeneration (AMD) Market Size by Type
2.3.1 Age Related Macular Degeneration (AMD) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
2.4 Age Related Macular Degeneration (AMD) Segment by Application
2.4.1 Men
2.4.2 Woman
2.5 Age Related Macular Degeneration (AMD) Market Size by Application
2.5.1 Age Related Macular Degeneration (AMD) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
3 AGE RELATED MACULAR DEGENERATION (AMD) MARKET SIZE BY PLAYER
3.1 Age Related Macular Degeneration (AMD) Market Size Market Share by Players
3.1.1 Global Age Related Macular Degeneration (AMD) Revenue by Players (2019-2024)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2019-2024)
3.2 Global Age Related Macular Degeneration (AMD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AGE RELATED MACULAR DEGENERATION (AMD) BY REGIONS
4.1 Age Related Macular Degeneration (AMD) Market Size by Regions (2019-2024)
4.2 Americas Age Related Macular Degeneration (AMD) Market Size Growth (2019-2024)
4.3 APAC Age Related Macular Degeneration (AMD) Market Size Growth (2019-2024)
4.4 Europe Age Related Macular Degeneration (AMD) Market Size Growth (2019-2024)
4.5 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
5.2 Americas Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024)
5.3 Americas Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024)
6.2 APAC Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024)
6.3 APAC Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Age Related Macular Degeneration (AMD) by Country (2019-2024)
7.2 Europe Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024)
7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Age Related Macular Degeneration (AMD) by Region (2019-2024)
8.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024)
8.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AGE RELATED MACULAR DEGENERATION (AMD) MARKET FORECAST
10.1 Global Age Related Macular Degeneration (AMD) Forecast by Regions (2025-2030)
10.1.1 Global Age Related Macular Degeneration (AMD) Forecast by Regions (2025-2030)
10.1.2 Americas Age Related Macular Degeneration (AMD) Forecast
10.1.3 APAC Age Related Macular Degeneration (AMD) Forecast
10.1.4 Europe Age Related Macular Degeneration (AMD) Forecast
10.1.5 Middle East & Africa Age Related Macular Degeneration (AMD) Forecast
10.2 Americas Age Related Macular Degeneration (AMD) Forecast by Country (2025-2030)
10.2.1 United States Age Related Macular Degeneration (AMD) Market Forecast
10.2.2 Canada Age Related Macular Degeneration (AMD) Market Forecast
10.2.3 Mexico Age Related Macular Degeneration (AMD) Market Forecast
10.2.4 Brazil Age Related Macular Degeneration (AMD) Market Forecast
10.3 APAC Age Related Macular Degeneration (AMD) Forecast by Region (2025-2030)
10.3.1 China Age Related Macular Degeneration (AMD) Market Forecast
10.3.2 Japan Age Related Macular Degeneration (AMD) Market Forecast
10.3.3 Korea Age Related Macular Degeneration (AMD) Market Forecast
10.3.4 Southeast Asia Age Related Macular Degeneration (AMD) Market Forecast
10.3.5 India Age Related Macular Degeneration (AMD) Market Forecast
10.3.6 Australia Age Related Macular Degeneration (AMD) Market Forecast
10.4 Europe Age Related Macular Degeneration (AMD) Forecast by Country (2025-2030)
10.4.1 Germany Age Related Macular Degeneration (AMD) Market Forecast
10.4.2 France Age Related Macular Degeneration (AMD) Market Forecast
10.4.3 UK Age Related Macular Degeneration (AMD) Market Forecast
10.4.4 Italy Age Related Macular Degeneration (AMD) Market Forecast
10.4.5 Russia Age Related Macular Degeneration (AMD) Market Forecast
10.5 Middle East & Africa Age Related Macular Degeneration (AMD) Forecast by Region (2025-2030)
10.5.1 Egypt Age Related Macular Degeneration (AMD) Market Forecast
10.5.2 South Africa Age Related Macular Degeneration (AMD) Market Forecast
10.5.3 Israel Age Related Macular Degeneration (AMD) Market Forecast
10.5.4 Turkey Age Related Macular Degeneration (AMD) Market Forecast
10.5.5 GCC Countries Age Related Macular Degeneration (AMD) Market Forecast
10.6 Global Age Related Macular Degeneration (AMD) Forecast by Type (2025-2030)
10.7 Global Age Related Macular Degeneration (AMD) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Age Related Macular Degeneration (AMD) Product Offered
11.1.3 Bayer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 F. HoffmannLa Roche
11.2.1 F. HoffmannLa Roche Company Information
11.2.2 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product Offered
11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 F. HoffmannLa Roche Main Business Overview
11.2.5 F. HoffmannLa Roche Latest Developments
11.3 Regeneron
11.3.1 Regeneron Company Information
11.3.2 Regeneron Age Related Macular Degeneration (AMD) Product Offered
11.3.3 Regeneron Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Regeneron Main Business Overview
11.3.5 Regeneron Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Age Related Macular Degeneration (AMD) Product Offered
11.4.3 Novartis Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Valeant
11.5.1 Valeant Company Information
11.5.2 Valeant Age Related Macular Degeneration (AMD) Product Offered
11.5.3 Valeant Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Valeant Main Business Overview
11.5.5 Valeant Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Age Related Macular Degeneration (AMD) Product Offered
11.6.3 Pfizer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Age Related Macular Degeneration (AMD) Market Size 2019-2030
2.1.2 Age Related Macular Degeneration (AMD) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Age Related Macular Degeneration (AMD) Segment by Type
2.2.1 Wet AMD
2.2.2 Dry AMD
2.3 Age Related Macular Degeneration (AMD) Market Size by Type
2.3.1 Age Related Macular Degeneration (AMD) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
2.4 Age Related Macular Degeneration (AMD) Segment by Application
2.4.1 Men
2.4.2 Woman
2.5 Age Related Macular Degeneration (AMD) Market Size by Application
2.5.1 Age Related Macular Degeneration (AMD) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
3 AGE RELATED MACULAR DEGENERATION (AMD) MARKET SIZE BY PLAYER
3.1 Age Related Macular Degeneration (AMD) Market Size Market Share by Players
3.1.1 Global Age Related Macular Degeneration (AMD) Revenue by Players (2019-2024)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2019-2024)
3.2 Global Age Related Macular Degeneration (AMD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AGE RELATED MACULAR DEGENERATION (AMD) BY REGIONS
4.1 Age Related Macular Degeneration (AMD) Market Size by Regions (2019-2024)
4.2 Americas Age Related Macular Degeneration (AMD) Market Size Growth (2019-2024)
4.3 APAC Age Related Macular Degeneration (AMD) Market Size Growth (2019-2024)
4.4 Europe Age Related Macular Degeneration (AMD) Market Size Growth (2019-2024)
4.5 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
5.2 Americas Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024)
5.3 Americas Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024)
6.2 APAC Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024)
6.3 APAC Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Age Related Macular Degeneration (AMD) by Country (2019-2024)
7.2 Europe Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024)
7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Age Related Macular Degeneration (AMD) by Region (2019-2024)
8.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024)
8.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AGE RELATED MACULAR DEGENERATION (AMD) MARKET FORECAST
10.1 Global Age Related Macular Degeneration (AMD) Forecast by Regions (2025-2030)
10.1.1 Global Age Related Macular Degeneration (AMD) Forecast by Regions (2025-2030)
10.1.2 Americas Age Related Macular Degeneration (AMD) Forecast
10.1.3 APAC Age Related Macular Degeneration (AMD) Forecast
10.1.4 Europe Age Related Macular Degeneration (AMD) Forecast
10.1.5 Middle East & Africa Age Related Macular Degeneration (AMD) Forecast
10.2 Americas Age Related Macular Degeneration (AMD) Forecast by Country (2025-2030)
10.2.1 United States Age Related Macular Degeneration (AMD) Market Forecast
10.2.2 Canada Age Related Macular Degeneration (AMD) Market Forecast
10.2.3 Mexico Age Related Macular Degeneration (AMD) Market Forecast
10.2.4 Brazil Age Related Macular Degeneration (AMD) Market Forecast
10.3 APAC Age Related Macular Degeneration (AMD) Forecast by Region (2025-2030)
10.3.1 China Age Related Macular Degeneration (AMD) Market Forecast
10.3.2 Japan Age Related Macular Degeneration (AMD) Market Forecast
10.3.3 Korea Age Related Macular Degeneration (AMD) Market Forecast
10.3.4 Southeast Asia Age Related Macular Degeneration (AMD) Market Forecast
10.3.5 India Age Related Macular Degeneration (AMD) Market Forecast
10.3.6 Australia Age Related Macular Degeneration (AMD) Market Forecast
10.4 Europe Age Related Macular Degeneration (AMD) Forecast by Country (2025-2030)
10.4.1 Germany Age Related Macular Degeneration (AMD) Market Forecast
10.4.2 France Age Related Macular Degeneration (AMD) Market Forecast
10.4.3 UK Age Related Macular Degeneration (AMD) Market Forecast
10.4.4 Italy Age Related Macular Degeneration (AMD) Market Forecast
10.4.5 Russia Age Related Macular Degeneration (AMD) Market Forecast
10.5 Middle East & Africa Age Related Macular Degeneration (AMD) Forecast by Region (2025-2030)
10.5.1 Egypt Age Related Macular Degeneration (AMD) Market Forecast
10.5.2 South Africa Age Related Macular Degeneration (AMD) Market Forecast
10.5.3 Israel Age Related Macular Degeneration (AMD) Market Forecast
10.5.4 Turkey Age Related Macular Degeneration (AMD) Market Forecast
10.5.5 GCC Countries Age Related Macular Degeneration (AMD) Market Forecast
10.6 Global Age Related Macular Degeneration (AMD) Forecast by Type (2025-2030)
10.7 Global Age Related Macular Degeneration (AMD) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Age Related Macular Degeneration (AMD) Product Offered
11.1.3 Bayer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 F. HoffmannLa Roche
11.2.1 F. HoffmannLa Roche Company Information
11.2.2 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product Offered
11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 F. HoffmannLa Roche Main Business Overview
11.2.5 F. HoffmannLa Roche Latest Developments
11.3 Regeneron
11.3.1 Regeneron Company Information
11.3.2 Regeneron Age Related Macular Degeneration (AMD) Product Offered
11.3.3 Regeneron Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Regeneron Main Business Overview
11.3.5 Regeneron Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Age Related Macular Degeneration (AMD) Product Offered
11.4.3 Novartis Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Valeant
11.5.1 Valeant Company Information
11.5.2 Valeant Age Related Macular Degeneration (AMD) Product Offered
11.5.3 Valeant Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Valeant Main Business Overview
11.5.5 Valeant Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Age Related Macular Degeneration (AMD) Product Offered
11.6.3 Pfizer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Age Related Macular Degeneration (AMD) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Wet AMD
Table 3. Major Players of Dry AMD
Table 4. Age Related Macular Degeneration (AMD) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Table 7. Age Related Macular Degeneration (AMD) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Table 10. Global Age Related Macular Degeneration (AMD) Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Player (2019-2024)
Table 12. Age Related Macular Degeneration (AMD) Key Players Head office and Products Offered
Table 13. Age Related Macular Degeneration (AMD) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Age Related Macular Degeneration (AMD) Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Regions (2019-2024)
Table 18. Global Age Related Macular Degeneration (AMD) Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Country (2019-2024)
Table 22. Americas Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Table 24. Americas Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Table 26. APAC Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Region (2019-2024)
Table 28. APAC Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Table 30. APAC Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Table 32. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Country (2019-2024)
Table 34. Europe Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Table 36. Europe Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Age Related Macular Degeneration (AMD)
Table 45. Key Market Challenges & Risks of Age Related Macular Degeneration (AMD)
Table 46. Key Industry Trends of Age Related Macular Degeneration (AMD)
Table 47. Global Age Related Macular Degeneration (AMD) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Age Related Macular Degeneration (AMD) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Age Related Macular Degeneration (AMD) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Bayer Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 52. Bayer Age Related Macular Degeneration (AMD) Product Offered
Table 53. Bayer Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Bayer Main Business
Table 55. Bayer Latest Developments
Table 56. F. HoffmannLa Roche Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 57. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product Offered
Table 58. F. HoffmannLa Roche Main Business
Table 59. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. F. HoffmannLa Roche Latest Developments
Table 61. Regeneron Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 62. Regeneron Age Related Macular Degeneration (AMD) Product Offered
Table 63. Regeneron Main Business
Table 64. Regeneron Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Regeneron Latest Developments
Table 66. Novartis Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 67. Novartis Age Related Macular Degeneration (AMD) Product Offered
Table 68. Novartis Main Business
Table 69. Novartis Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Novartis Latest Developments
Table 71. Valeant Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 72. Valeant Age Related Macular Degeneration (AMD) Product Offered
Table 73. Valeant Main Business
Table 74. Valeant Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Valeant Latest Developments
Table 76. Pfizer Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 77. Pfizer Age Related Macular Degeneration (AMD) Product Offered
Table 78. Pfizer Main Business
Table 79. Pfizer Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Pfizer Latest Developments
Table 1. Age Related Macular Degeneration (AMD) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Wet AMD
Table 3. Major Players of Dry AMD
Table 4. Age Related Macular Degeneration (AMD) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Table 7. Age Related Macular Degeneration (AMD) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Table 10. Global Age Related Macular Degeneration (AMD) Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Player (2019-2024)
Table 12. Age Related Macular Degeneration (AMD) Key Players Head office and Products Offered
Table 13. Age Related Macular Degeneration (AMD) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Age Related Macular Degeneration (AMD) Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Regions (2019-2024)
Table 18. Global Age Related Macular Degeneration (AMD) Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Country (2019-2024)
Table 22. Americas Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Table 24. Americas Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Table 26. APAC Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Region (2019-2024)
Table 28. APAC Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Table 30. APAC Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Table 32. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Country (2019-2024)
Table 34. Europe Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Table 36. Europe Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Age Related Macular Degeneration (AMD)
Table 45. Key Market Challenges & Risks of Age Related Macular Degeneration (AMD)
Table 46. Key Industry Trends of Age Related Macular Degeneration (AMD)
Table 47. Global Age Related Macular Degeneration (AMD) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Age Related Macular Degeneration (AMD) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Age Related Macular Degeneration (AMD) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Bayer Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 52. Bayer Age Related Macular Degeneration (AMD) Product Offered
Table 53. Bayer Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Bayer Main Business
Table 55. Bayer Latest Developments
Table 56. F. HoffmannLa Roche Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 57. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product Offered
Table 58. F. HoffmannLa Roche Main Business
Table 59. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. F. HoffmannLa Roche Latest Developments
Table 61. Regeneron Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 62. Regeneron Age Related Macular Degeneration (AMD) Product Offered
Table 63. Regeneron Main Business
Table 64. Regeneron Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Regeneron Latest Developments
Table 66. Novartis Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 67. Novartis Age Related Macular Degeneration (AMD) Product Offered
Table 68. Novartis Main Business
Table 69. Novartis Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Novartis Latest Developments
Table 71. Valeant Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 72. Valeant Age Related Macular Degeneration (AMD) Product Offered
Table 73. Valeant Main Business
Table 74. Valeant Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Valeant Latest Developments
Table 76. Pfizer Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 77. Pfizer Age Related Macular Degeneration (AMD) Product Offered
Table 78. Pfizer Main Business
Table 79. Pfizer Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Pfizer Latest Developments
LIST OF FIGURES
Figure 1. Age Related Macular Degeneration (AMD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Age Related Macular Degeneration (AMD) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Age Related Macular Degeneration (AMD) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Age Related Macular Degeneration (AMD) Sales Market Share by Country/Region (2023)
Figure 8. Age Related Macular Degeneration (AMD) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2023
Figure 10. Age Related Macular Degeneration (AMD) in Men
Figure 11. Global Age Related Macular Degeneration (AMD) Market: Men (2019-2024) & ($ Millions)
Figure 12. Age Related Macular Degeneration (AMD) in Woman
Figure 13. Global Age Related Macular Degeneration (AMD) Market: Woman (2019-2024) & ($ Millions)
Figure 14. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2023
Figure 15. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Player in 2023
Figure 16. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Age Related Macular Degeneration (AMD) Market Size 2019-2024 ($ Millions)
Figure 18. APAC Age Related Macular Degeneration (AMD) Market Size 2019-2024 ($ Millions)
Figure 19. Europe Age Related Macular Degeneration (AMD) Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size 2019-2024 ($ Millions)
Figure 21. Americas Age Related Macular Degeneration (AMD) Value Market Share by Country in 2023
Figure 22. United States Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Region in 2023
Figure 27. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2023
Figure 28. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2023
Figure 29. China Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Country in 2023
Figure 36. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Figure 37. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Figure 38. Germany Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 52. APAC Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 53. Europe Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 55. United States Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 56. Canada Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 59. China Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 60. Japan Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 61. Korea Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 63. India Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 64. Australia Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 65. Germany Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 66. France Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 67. UK Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 68. Italy Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 69. Russia Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 70. Spain Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 73. Israel Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 76. Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Age Related Macular Degeneration (AMD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Age Related Macular Degeneration (AMD) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Age Related Macular Degeneration (AMD) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Age Related Macular Degeneration (AMD) Sales Market Share by Country/Region (2023)
Figure 8. Age Related Macular Degeneration (AMD) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2023
Figure 10. Age Related Macular Degeneration (AMD) in Men
Figure 11. Global Age Related Macular Degeneration (AMD) Market: Men (2019-2024) & ($ Millions)
Figure 12. Age Related Macular Degeneration (AMD) in Woman
Figure 13. Global Age Related Macular Degeneration (AMD) Market: Woman (2019-2024) & ($ Millions)
Figure 14. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2023
Figure 15. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Player in 2023
Figure 16. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Age Related Macular Degeneration (AMD) Market Size 2019-2024 ($ Millions)
Figure 18. APAC Age Related Macular Degeneration (AMD) Market Size 2019-2024 ($ Millions)
Figure 19. Europe Age Related Macular Degeneration (AMD) Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size 2019-2024 ($ Millions)
Figure 21. Americas Age Related Macular Degeneration (AMD) Value Market Share by Country in 2023
Figure 22. United States Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Region in 2023
Figure 27. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2023
Figure 28. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2023
Figure 29. China Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Country in 2023
Figure 36. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Figure 37. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Figure 38. Germany Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Age Related Macular Degeneration (AMD) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 52. APAC Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 53. Europe Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 55. United States Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 56. Canada Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 59. China Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 60. Japan Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 61. Korea Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 63. India Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 64. Australia Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 65. Germany Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 66. France Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 67. UK Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 68. Italy Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 69. Russia Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 70. Spain Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 73. Israel Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Age Related Macular Degeneration (AMD) Market Size 2025-2030 ($ Millions)
Figure 76. Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Application (2025-2030)
